Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Functional Genomics Market Size, Value And Growth Trajectory Through 2030
The functional genomics market has seen rapid expansion in recent years. This market is expected to increase from $14.84 billion in 2025 to $16.96 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. Historically, this growth was driven by factors such as the expansion of genomics research funding, the growing availability of sequencing technologies, an increase in academic genomics research, rising demand for functional gene analysis, and enhancements in bioinformatics tools.
The functional genomics market is poised for significant expansion in the coming years. Projections indicate its value will reach $28.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.1%. This growth during the forecast period is propelled by factors such as the greater embrace of precision medicine, increasing capital directed towards genomic data analytics, the broadening of gene editing research applications, intensified partnerships between academic institutions and industry, and a heightened emphasis on translational genomics research. Key developments anticipated in this period encompass the wider utilization of high-throughput functional genomics instruments, the enhanced integration of multi-omics analysis platforms, the increasing application of AI in interpreting gene functions, the expansion of automated genomic processes, and a stronger focus on uncovering disease mechanisms.
Get A Free Sample Report With In-Depth Market Insights:
Functional Genomics Market Growth Factors: What’s Supporting Expansion?
Elevated spending on research and development (R&D) is anticipated to drive the expansion of the functional genomics market in the future. R&D represents a structured approach aimed at originating, refining, and advancing products, methods, or understanding through systematic inquiry and practical testing. Businesses are channeling greater funds into R&D as they prioritize innovation to maintain a competitive edge, prompting increased allocation of resources to develop novel products, enhance existing technologies, and seize new market prospects. Such investment greatly aids functional genomics by furthering the discovery and examination of gene roles, thereby deepening comprehension of intricate biological mechanisms and facilitating the development of targeted therapeutic interventions. As an illustration, Biospace, a US-based online pharmaceuticals platform, reported in February 2024 that worldwide biopharma R&D funding increased from $61 billion in 2022 to $72 billion in 2023. Consequently, the growing financial commitment to research and development is fueling the expansion of the functional genomics market.
Functional Genomics Market Segment Landscape: Which Areas Lead Development?
The functional genomics market covered in this report is segmented –
1) By Product: Kits And Assays, Instruments
2) By Technology: Next-Generation Sequencing (NGS), Microarray Analysis, CRISPR And Gene Editing Technologies, RNA Sequencing (RNA-Seq)
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CROs), Clinical Laboratories, Agricultural Biotechnology Companies
Subsegments:
1) By Kits And Assays: PCR Kits, Microarray Kits, NGS Kits, Reagents, Enzymes
2) By Instruments: Sequencers, Microarray Scanners, PCR Instruments, Automation Systems
Functional Genomics Market Trends Shaping Long-Term Demand
Leading companies within the functional genomics market are prioritizing the development of sophisticated methodologies, such as high-throughput sequencing, to deliver precise and comprehensive understanding of complex genomes. High-throughput sequencing is a technique that enables the quick and parallel analysis of vast quantities of DNA or RNA, allowing for extensive examination of genetic data. As an illustration, in February 2025, Roche, a pharmaceutical firm based in Switzerland, introduced its sequencing by expansion (SBX) technology, thereby establishing a novel class of next-generation sequencing. The SBX chemistry, when combined with an advanced sensor module, facilitates exceptionally rapid, high-throughput sequencing that is both flexible and expandable for a broad spectrum of applications. This innovative approach converts the sequence of DNA or RNA into an identifiable proxy polymer known as an Xpandomer through a specific biochemical mechanism. These Xpandomers, which are fifty times longer than the original nucleic acid, transform genetic sequence data into robust, clear signals with minimal interference, ensuring unambiguous and dependable identification. By employing a CMOS-based sensor with parallel processing, this method accomplishes remarkably precise single-molecule nanopore sequencing, characterized by outstanding rapidity and adaptability.
Functional Genomics Market Industry Leaders And Competitive Landscape
Major companies operating in the functional genomics market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Perkin Elmer Inc., Revvity Inc., Exact Sciences Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Integrated DNA Technologies Inc., Promega Corporation, Pacific Biosciences of California Inc., Genomics Ltd., MEDiC LLC, Enhanc3D Genomics Ltd., Samplix, Arima Genomics Inc., Phase Genomics Inc.
View The Full Functional Genomics Market Report:
Functional Genomics Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the functional genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the functional genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
